Novel Heterocyclic Compounds as Bromodomain Inhibitors
申请人:Liu Shuang
公开号:US20140179648A1
公开(公告)日:2014-06-26
The present disclosure relates to compounds, which are useful for inhibition of BET protein function by binding to bromodomains, and their use in therapy.
NOVEL HETEROCYCLIC COMPOUNDS AS BROMODOMAIN INHIBITORS
申请人:Zenith Epigenetics Ltd.
公开号:US20170143731A1
公开(公告)日:2017-05-25
The present disclosure relates to compounds, which are useful for inhibition of BET protein function by binding to bromodomains, and their use in therapy.